Health

New Theories and Findings From The Frontier of Ibogaine Research 

After publishing a new study investigating synthetic analogs for iboga molecules, scientist and co-founder of Gilgamesh Pharmaceuticals, Dalibor Sames, decided to take the compound he has described as an intelligent molecular machine.

Partners Announced for Texas Ibogaine Research Consortium Funding

The Texas Health and Human Services Commission (HHSC) has announced $50 million in awards to a collective of public universities across the state to establish the Texas Ibogaine Research Consortium.

From Nepal to Podcasts: The Viral Rise of Hallucinogenic “Mad Honey”

For millennia, Himalayan tribes have scaled cliffs to obtain psychoactive honey for its medicinal properties. However, in recent years, their sacred gift has been appropriated by thrill-seekers influenced by “podcast bros”, creating health and ecological complications.

New Mexico to Accelerate Its Launch of Therapeutic Psilocybin Access

New Mexico health officials announced plans to launch the state’s medical psilocybin therapy program by the end of December 2026 – a full year ahead of the legislative deadline.

Freedom To Heal Act Gathers Support

Supporters of the Freedom To Heal Act met with members of Congress and their staff this week seeking backing for legislation that would allow DEA-regulated medical use of Schedule I substances for patients with life-threatening conditions.

Minnesota Psychedelic Medicine Task Force Makes Recommendations

Thanks to organizing from local advocacy organizations, Minnesota has quietly become a hotbed of reform launching a psychedelic task force and deprioritized arrests related to entheogenic plants and fungi.

2025: The Year of Ibogaine Therapy

The future of ibogaine therapy was a central topic at the 2025 Psychedelic Science conference, where it was endorsed by former Texas governor Rick Perry and others. Other states are following suit, but some advocates worry about possible exploitation of the plant medicine.

MAPS Brings MDMA-Assisted Therapy to the War in Ukraine

Fifty-five therapists join a fleet of international practitioners to train in MDMA-assisted therapy and advance MAPS’ international goals for conflict zones.

Oregon’s Legal Psilocybin Industry: Growing Pains, Healing Gains

Has the psilocybin therapy industry peaked already in Oregon? Growth is slow, and uncertainty reigns, but safeguards seem to be working.

True REST and SoundSelf Layer Ketamine Therapy, Float Tanks and Tech

Entrepreneurs Nick Janicki of the float tank company True REST and Robin Arnott of the “digital psychedelic” company SoundSelf are teaming up to create centers that they say will offer clinical ketamine treatment together with prep and integration services including float tanks, music, and light technologies.